Julie A. Di Paolo,Randall Mark Jones,Daniel B. Tumas
申请号：
US15010906
公开号：
US20160220573A1
申请日:
2016.01.29
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Provided herein are methods that relate to a therapeutic strategy for treatment of cancer, including hematological malignancies. In particular, the methods include administration entospletinib and a Bcl-2 inhibitor, such as venetoclax, navitoclax, and ABT-737.
